CenterBook Partners LP Makes New $5.08 Million Investment in Cardinal Health, Inc. $CAH

CenterBook Partners LP purchased a new position in Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 24,697 shares of the company’s stock, valued at approximately $5,075,000.

A number of other large investors have also bought and sold shares of the stock. Versor Investments LP bought a new stake in shares of Cardinal Health in the 3rd quarter worth approximately $2,090,000. Nordea Investment Management AB grew its position in shares of Cardinal Health by 328.3% in the 4th quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after buying an additional 494,731 shares during the last quarter. Candriam S.C.A. grew its position in shares of Cardinal Health by 10.8% in the 3rd quarter. Candriam S.C.A. now owns 196,163 shares of the company’s stock worth $30,790,000 after buying an additional 19,155 shares during the last quarter. Victory Capital Management Inc. grew its position in shares of Cardinal Health by 44.9% in the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company’s stock worth $352,165,000 after buying an additional 707,495 shares during the last quarter. Finally, Public Sector Pension Investment Board grew its position in shares of Cardinal Health by 66.7% in the 3rd quarter. Public Sector Pension Investment Board now owns 30,007 shares of the company’s stock worth $4,710,000 after buying an additional 12,003 shares during the last quarter. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 0.0%

NYSE CAH opened at $205.79 on Monday. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60. The firm has a market capitalization of $48.20 billion, a PE ratio of 31.47, a P/E/G ratio of 1.12 and a beta of 0.52. The stock’s 50 day moving average is $202.53 and its 200 day moving average is $208.59.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same period in the previous year, the company posted $2.35 earnings per share. The firm’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts anticipate that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is presently 31.19%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Morgan Stanley lifted their price objective on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. Wells Fargo & Company cut their price objective on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research report on Friday, May 1st. Robert W. Baird set a $248.00 price objective on Cardinal Health in a research report on Friday, May 1st. Leerink Partners reiterated an “outperform” rating and issued a $275.00 price objective on shares of Cardinal Health in a research report on Monday, March 9th. Finally, Barclays lifted their price objective on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 24th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.